Table 2.
Clinical and Biochemical Follow Up in Individual SIE-03 during Monthly 5 Day Courses of Chelation Therapy with Disodium Calcium Edetate, 20 mg/kg twice/day
| 24 Hr Urine Mn (mcg/l) | Blood Mn (mcg/l) | UPDRS-III | Walking Test, 3 m (s) | |
|---|---|---|---|---|
| Baseline | 1.06 | 106.0 | 27 | 18 |
| Month 1 | 30.0 | 133.0 | 13 | 13 |
| Month 2 | 76.0 | 101.0 | 10 | 10 |
| Month 3 | 216.0 | 90.0 | 9 | 10 |
| Month 4 | 219.0 | 4.2 | 8 | 8 |
UPDRS-III is an abbreviation for Unified Parkinson Disease Rating Scale, part III (motor score). Higher scores correspond to more severe parkinsonism; the maximum score is 108.